- Bharat Biotech International Ltd has launched Nucelion Therapeutics, a wholly owned subsidiary focused on cell and gene therapy manufacturing. Based in Hyderabad’s Genome Valley, Nucelion will function as a Contract Research, Development and Manufacturing Organisation (CRDMO), providing comprehensive services for the development and production of advanced biological treatments. The initiative marks Bharat Biotech’s strategic entry into next-generation therapeutic technologies, expanding India’s footprint in the global biopharmaceutical sector.
Month: Current Affairs - November 03, 2025
Category: Science & Technology / Biotechnology